High-intensity chemotherapy and rituximab for the treatment of posttransplant lymphoproliferative disorder

Am J Clin Oncol. 2006 Apr;29(2):211-2. doi: 10.1097/01.coc.0000162640.27701.9f.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Humans
  • Liver Transplantation / adverse effects*
  • Lymphoproliferative Disorders / drug therapy*
  • Lymphoproliferative Disorders / etiology
  • Male
  • Rituximab
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab